LEONORI Lorenzo

Département de médecine interne > Service de rhumatologie

See author's contact details

Main Referenced Co-authors

Reginster, Jean-Yves (7)

Bruyère, Olivier (6)

Leroy, Mathieu (5)

Malaise, Michel (5)

Malaise, Olivier (5)

Main Referenced Keywords

Humans (2); Osteoporosis (2); Rheumatology (2); Absorptiometry, Photon (1); Aged (1);

Main Referenced Disciplines

Rheumatology (9)

Public health, health care sciences & services (6)

General & internal medicine (4)

Publications (total 12)

Search in publications

The most downloaded

25 downloads

MALAISE, M., CHAPELIER, N., DEWAEL, T., LEONORI, L., LEROY, M., Mailleux, E., André, B., Halleux, S., KAISER, M.-J., MALAISE, O., RIBBENS, C., RINKIN, C., VON FRENCKELL, C., & VOLDERS, A. (May 2020). Une révolution thérapeutique en rhumatologie : oui, mais… Revue Médicale de Liège, 75 (5-6), 369-375. https://hdl.handle.net/2268/289824

The most cited

35 citations (OpenAlex)

Reginster, J.-Y., Sarlet, N., LEJEUNE, E., & Leonori, L. (March 2005). Strontium Ranelate: A New Treatment for Postmenopausal Osteoporosis with a Dual Mode of Action. Current Osteoporosis Reports, 3 (1), 30-4. doi:10.1007/s11914-005-0025-7 https://hdl.handle.net/2268/25334

Salpetier, P., Mina, M., Seidel, L., LEROY, M., LEONORI, L., Malaise, M., Ribbens, C., & Malaise, O. (2022). Réalisation « systématique » ou « basée sur les recommandations » d’une radiographie du rachis dorsolombaire (Vertebral Fracture Assessment) lors d’un examen de densitométrie osseuse ? Revue du Rhumatisme. doi:10.1016/j.rhum.2022.10.152

https://hdl.handle.net/2268/302897

Peer reviewed

MALAISE, M., CHAPELIER, N., DEWAEL, T., LEONORI, L., LEROY, M., Mailleux, E., André, B., Halleux, S., KAISER, M.-J., MALAISE, O., RIBBENS, C., RINKIN, C., VON FRENCKELL, C., & VOLDERS, A. (May 2020). Une révolution thérapeutique en rhumatologie : oui, mais… Revue Médicale de Liège, 75 (5-6), 369-375.

https://hdl.handle.net/2268/289824

Editorial Reviewed verified by ORBi

Malaise, O., Detroz, M., Leroy, M., Leonori, L., SEIDEL, L., & Malaise, M. (2020). High detection rate of osteoporosis with screening of a general hospitalized population: a 6-year study in 6406 patients in a university hospital setting. BMC Musculoskeletal Disorders, 21 (1), 90. doi:10.1186/s12891-020-3116-9

https://hdl.handle.net/2268/256503

Peer Reviewed verified by ORBi

MALAISE, O., DETROZ, M., LEROY, M., LEONORI, L., SEIDEL, L., & MALAISE, M. (2019). SCREENING FOR OSTEOPOROSIS IN AN AMBULATORY AND HOSPITALIZED POPULATION: A 6- YEAR EXPERIENCE IN A UNIVERSITY HOSPITAL. Annals of the Rheumatic Diseases, 0840. doi:10.1136/annrheumdis-2019-eular.4221

https://hdl.handle.net/2268/268231

Peer Reviewed verified by ORBi

MALAISE, O., Detrooz, M., LEROY, M., LEONORI, L., SEIDEL, L., & MALAISE, M. (2018). Dépistage de l’ostéoporose dans une population ambulatoire et hospitalisée : une expérience de 6 ans au CHU de Liège. Revue du Rhumatisme.

https://hdl.handle.net/2268/268226

Peer Reviewed verified by ORBi

Zegels, B., LEONORI, L., Crozes, P., Uebelhart, D., Bruyère, O., & Reginster, J.-Y. (April 2013). Equivalence of a single dose (1200mg) compared to a 3-time a day dose (400mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis: Results of a randomized double blind placebo controlled study. Osteoporosis International, 24 (Suppl.1), 383.

https://hdl.handle.net/2268/147562

Peer Reviewed verified by ORBi

Bruyère, O., Fossi, M., Zegels, B., LEONORI, L., Hiligsmann, M., Neuprez, A., & Reginster, J.-Y. (April 2013). Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security and the new suggested FRAX criteria. Rheumatology International, 33 (4), 973-8. doi:10.1007/s00296-012-2460-y

https://hdl.handle.net/2268/128216

Peer Reviewed verified by ORBi

Bruyère, O., Zegels, B., LEONORI, L., Rabenda, V., Janssen, A., Bourges, C., & Reginster, J.-Y. (March 2012). Effect of collagen hydrolysate in articular pain: A 6-month randomized, double-blind, placebo controlled study. Osteoporosis International, 23 (Suppl. 2), 362-363.

https://hdl.handle.net/2268/115405

Peer Reviewed verified by ORBi

Bruyère, O., Neuprez, A., Fossi, M., Zegels, B., LEONORI, L., Hiligsmann, M., & Reginster, J.-Y. (March 2011). Reimbursement of drugs against osteoporosis based on FRAX® instead of the current criteria would reduce by 30% the cost (in a societal perspective) of anti-osteoporosis treatment in Belgium. Osteoporosis International, 22 (Suppl.1), 333-334.

https://hdl.handle.net/2268/88491

Peer Reviewed verified by ORBi

Bruyère, O., Neuprez, A., Fossi, M., Beaudart, C., Zegels, B., Leonori, L., Hiligsmann, M., & Reginster, J.-Y. (November 2010). Le remboursement des traitements contre l'ostéoporose basé sur l'utilisation de l'outil FRAX plutôt que sur les critères actuels permettrait de réduire de 30% le coût, dans une perspective sociétale, du traitement de l'ostéoporose en Belgique. Revue du Rhumatisme, 77 (Suppl.3), 66-67.

https://hdl.handle.net/2268/82829

Peer Reviewed verified by ORBi

Bruyère, O., Kothari, M., Zaim, S., White, D., Peterfy, C., Genant, H. K., Ethgen, D., Montague, T., Burlet, N., LEONORI, L., & Reginster, J.-Y. (March 2005). One-year progression of knee osteoarthritis: correlations between X-Rays and magnetic resonance imaging changes. Osteoporosis International, 16 (Suppl.3), 46-47.

https://hdl.handle.net/2268/86682

Peer Reviewed verified by ORBi

Reginster, J.-Y., Sarlet, N., LEJEUNE, E., & Leonori, L. (March 2005). Strontium Ranelate: A New Treatment for Postmenopausal Osteoporosis with a Dual Mode of Action. Current Osteoporosis Reports, 3 (1), 30-4. doi:10.1007/s11914-005-0025-7

https://hdl.handle.net/2268/25334

Peer Reviewed verified by ORBi